PCSA·74275C403·US·equity·Healthcare - Biotechnology-Activist
PCSA (PROCESSA PHARMACEUTICALS INC) is held by 5 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($62,768), UBS Group AG ($6,391), CITIGROUP INC ($35). Net institutional sentiment: Mixed.
See how PCSA's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer